Cargando…
Diagnostic and therapeutic implications of genetic heterogeneity in myeloid neoplasms uncovered by comprehensive mutational analysis
While growing use of comprehensive mutational analysis has led to the discovery of innumerable genetic alterations associated with various myeloid neoplasms, the under-recognized phenomenon of genetic heterogeneity within such neoplasms creates a potential for diagnostic confusion. Here, we describe...
Autores principales: | Choi, Sarah M., Goldenson, Ben, Peterson, Lo Ann, Dinner, Shira, Stein, Brady L., Behdad, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614759/ https://www.ncbi.nlm.nih.gov/pubmed/28975067 http://dx.doi.org/10.1016/j.lrr.2017.09.001 |
Ejemplares similares
-
The Heterogeneous Complexity of Myeloid Neoplasm: Multi-Level Approaches to Study the Disease
por: Awada, Hussein, et al.
Publicado: (2023) -
Targeting megakaryocytic induced fibrosis by AURKA inhibition in the myeloproliferative neoplasms
por: Wen, Qiang Jeremy, et al.
Publicado: (2015) -
AKT is a therapeutic target in myeloproliferative neoplasms
por: Khan, Irum, et al.
Publicado: (2013) -
P545: VENETOCLAX (VEN) COMBINED WITH FLAG-IDA IS AN EFFECTIVE REGIMEN FOR PATIENTS (PTS) WITH NEWLY DIAGNOSED (ND) AND RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
por: Burkart, Madelyn, et al.
Publicado: (2023) -
Co-occurrence of myeloid neoplasm and plasma cell neoplasm
por: Jum’ah, Husam, et al.
Publicado: (2022)